Shopping Cart
Remove All
Your shopping cart is currently empty
TAT-P110 is a peptide inhibitor that disrupts the interaction between Drp1 and Fis1, effectively reducing pathological changes in various models of neurodegenerative diseases, ischemia, and sepsis without impairing the physiological function of Drp1.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | TAT-P110 is a peptide inhibitor that disrupts the interaction between Drp1 and Fis1, effectively reducing pathological changes in various models of neurodegenerative diseases, ischemia, and sepsis without impairing the physiological function of Drp1. |
| In vitro | TAT-P110 effectively prevented the reduction in the number of cells with fused mitochondria caused by LPS. The percentages of cells with fused mitochondria are as follows: 37% (LPS + P110), 36% (LPS + SC9), and 38% (without LPS). |
| Synonyms | P110 |
| Molecular Weight | 2412.76 |
| Formula | C100H178N44O26 |
| Cas No. | 2247617-97-4 |
| Smiles | C([C@@H](NC([C@@H](NC([C@@H](NC(CNC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@H](CC1=CC=C(O)C=C1)N)=O)=O)CCCNC(=N)N)=O)CCCCN)=O)CCCCN)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCC(N)=O)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)=O)=O)CC(O)=O)=O)CC(C)C)=O)CC(C)C)(=O)N2[C@H](C(N[C@H](C(NCC(N[C@H](C(O)=O)CO)=O)=O)CCCNC(=N)N)=O)CCC2 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.